Project Grant R01EB035146
Award Date
8/1/24
Completion Date
5/31/28
Dollars Obligated
$1.6M
Federal Agency
National Institute of Biomedical Imaging and Bioenginering
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
New York, NY 10012, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), provides $963,619 to Osem Fluidics Inc. to develop 3D-printed microfluidic channel architectures to precisely control the structure and properties of lipid nanoparticles (LNPs) for improved nucleic acid delivery. The research aims to overcome limitations of current LNP manufacturing methods by designing, simulating, and testing...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training program provides $386,190 to Rensselaer Polytechnic Institute (RPI) for the period of August 1, 2024 to May 31, 2029. The project aims to explore the development of new approaches for enhancing the function of biomedical and biological interfaces through self-assembled multifunctional biointerfaces. Key research objectives include: 1) creating...
The National Institute of General Medical Sciences (NIGMS) awarded a $435,226 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Arkansas to develop a hyperstable and bioactive fibroblast growth factor (FGF1-FGF2) dimer for effective healing of diabetic skin wounds. The key objectives of this 3-year project, which commenced on September 10, 2024, are: 1) Designing a hyperstable and bioactive FGF1-FGF2 dimer and its variants; 2) Developing...
This $457,390 Project Grant award from the National Science Foundation's (NSF) Division of Materials Research aims to develop a new mRNA delivery system based on functional phosphoserine (PS) lipids. The award will support research to understand the targeted and immunomodulatory properties of these zwitterionic functional materials for mRNA delivery, with potential applications in gene therapy, protein-replacement therapy, and cancer immunotherapy. Key objectives include enhancing mRNA...
This $1,095,274 federal Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) seeks to develop complementary biotherapeutic delivery platforms to overcome immune system barriers and enable sustained gene therapy vector re-delivery. The grant funds three key research programs: 1) Targeted delivery of regulatory T cells to transgene persistence sites to modulate immune responses, 2) Selective delivery...
This federal Project Grant award, valued at $455,940.00 and awarded by the U.S. Department of Health and Human Services' National Institute of General Medical Sciences (CFDA 93.859 Biomedical Research and Research Training Program), supports research to investigate the biophysical properties of intrinsically disordered proteins (IDPs) when confined to nanoparticle constructs. The primary objectives are to 1) reveal how nanoparticle binding influences the structural plasticity of IDPs in response...
This federal Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under CFDA program 93.859 - Biomedical Research and Research Training, supports Rejuvenation Technologies Inc. (RTI) in developing advanced lipid nanoparticle (LNP) delivery vehicles capable of efficiently transporting modified mRNA encoding telomerase (TERT) to specific progenitor cell types. The goal is to extend the regenerative capacity of these cells, mitigating the vicious cycle of...
This $851,000 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program aims to develop a novel research tool for high-throughput screening of gene-carrying nanoparticles. The key product being developed is a peptoid-based barcode system that will enable accurate and efficient in vivo biodistribution studies of multiple...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), provides $198,646 to the Colorado School of Mines to develop machine learning-guided polymeric nanocarriers for efficient and safe delivery of ribonucleoproteins (RNPs) to hematopoietic stem and progenitor cells (HSPCs). The key objectives are to: 1) Engineer...
This $543,826 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to develop novel bioengineered regenerative medicine solutions for vascular tissue engineering. The research project, conducted at the University of Pittsburgh, focuses on understanding the mechanisms behind injury-inducible, in vivo vasculogenic reprogramming using a...